2m 2m 2m 2m 2m 2m 2m
Incyte (INCY)
NASDAQ
$119.95-$1.52 (-1.25%)
Price as of Sep 11, 2026 7:30 PM EDT- $24.6BMarket Cap
- 46.17%1-Year Change
- BiotechnologyIndustry
Incyte (INCY)
$119.95-$1.52 (-1.25%)
INCY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $121.47 | ||
Change | -$1.81 (-1.47%) | ||
Open | $124.35 | ||
High | $124.35 | ||
Low | $121.42 | ||
Previous Close | $123.28 | ||
Volume | 1,425,198 | ||
30-Day Average Volume | 1,235,603 | ||
1-Week Change | -4.17% | ||
1-Month Change | 0.33% | ||
1-Year Change | 46.17% | ||
3-Year Change | 88.59% | ||
5-Year Change | 70.80% | ||
Fundamentals | |||
Shares Outstanding | 202.7M | ||
Total Assets | $7.9B | ||
Market Cap | $24.6B | ||
Enterprise Value | $20.6B | ||
Period: QTR TTM FY | |||
Revenue | $1.5B | ||
Net Income | $585.6M | ||
Free Cash Flow | $507.7M | ||
EBIT | $751.5M | ||
EBITDA | $778.0M | ||
Net Working Capital | $4.7B | ||
EPS | $2.81 | ||
Enterprise Value/EBITDA | 27 | ||
Enterprise Value/Revenue | 14 | ||
P/B | 4 | ||
P/E | 43 | ||
PEG | 0 | ||
Price/Free Cash Flow | 49 | ||
Price/Operating Cash Flow | 49 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue